HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Diagnostic value of D-dimer and antithrombin-III levels in predicting prosthetic heart valve thrombosis.

Abstract
The aim of this prospective study was to investigate the diagnostic value of plasma D-dimer levels and antithrombin-III activity in predicting prosthetic valve thrombus. The study group comprised 97 consecutive patients with prosthetic heart valves (59 with mitral, 21 with aortic, and 17 with both mitral and aortic prostheses) and 35 healthy control subjects. Six patients presented with symptoms of obstruction; the remaining 91 were asymptomatic. Patients were evaluated by both transthoracic and transesophageal echocardiography. Asymptomatic nonobstructive thrombus was detected in 13 patients (13%), whereas obstructive thrombus was demonstrated in all symptomatic patients. Plasma antithrombin-III levels of patients with prosthetic valve thrombi were slightly lower than those of patients without thrombus and of the control group, but the difference was not statistically significant. However, significantly higher plasma D-dimer levels were observed in patients with prosthetic valve thrombi, compared with patients without thrombus and the control group (735 +/- 633 microg/L, 372 +/- 342 microg/L, and 228 +/- 219 microg/L, respectively). Valve thrombus, the prosthetic heart valve itself, and INR levels were identified as major determinants of plasma D-dimer levels. A plasma D-dimer level of >445 microg/L predicted the presence of a prosthetic valve thrombus with 57.8% sensitivity and 83.3% specificity (positive predictive value, 47.8%; negative predictive value, 87.8%). Current data suggest that increased plasma D-dimer levels can be clinically helpful in predicting the presence of prosthetic valve thrombus. Plasma antithrombin-III activity does not seem to have a diagnostic value in predicting prosthetic valve thrombi.
AuthorsCem Nazli, Ozan Kinay, Bahanttin Tunc, Oktay Ergene, Omer Gedikli, Ali Ayata, Abdullah Dogan, Ahmet Altinbas, Ulku Ergene, Mehmet Ozaydin, Turan Yavuz, Halil Kahraman
JournalTexas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital (Tex Heart Inst J) Vol. 30 Issue 4 Pg. 268-79 ( 2003) ISSN: 0730-2347 [Print] United States
PMID14677736 (Publication Type: Evaluation Studies, Journal Article)
Chemical References
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Antithrombin III
Topics
  • Adult
  • Antithrombin III (metabolism)
  • Aortic Valve (ultrasonography)
  • Female
  • Fibrin Fibrinogen Degradation Products (metabolism)
  • Heart Valve Diseases (diagnosis, etiology, ultrasonography)
  • Heart Valve Prosthesis (adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve (ultrasonography)
  • Predictive Value of Tests
  • Prospective Studies
  • Reproducibility of Results
  • Thrombosis (diagnosis, etiology, ultrasonography)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: